Cellular plasticity and immune microenvironment of malignant pleural effusion are associated with EGFR-TKI resistance in non–small-cell lung carcinoma

• DOI: 10.1016/j.isci.2022.105358
• Publication Date: 2022-10-13T12:54:37Z
• Authors: Hyoung-oh Jeong; Hayoon Lee; Hyemin Kim; Jinho Jang; Seunghoon Kim; Taejoo Hwang; David Whee-Young ...; Hong Sook Kim; Naeun Lee; Yoo Mi Lee; Sehhoon Park; Hyun Ae Jung; Jong-Mu Sun; Jin Seok Ahn; Myung-Ju Ahn; Keunchil Park; Semin Lee; Se-Hoon Lee
• Keywords: immunology; transcriptomics; 0303 health sciences; 03 medical and health sciences; Science; 616; Q; 610; Article; Cancer; omics; 3. Good health

Malignant pleural effusion (MPE) is a complication of lung cancer that can be used as an alternative method for tissue sampling because it is generally simple and minimally invasive. Our study evaluated the diagnostic potential of non-small-cell lung carcinoma (NSCLC)-associated MPE in terms of understanding tumor heterogeneity and identifying response factors for EGFR tyrosine kinase inhibitor (TKI) therapy. We performed a single-cell RNA sequencing analysis of 31,743 cells isolated from the MPEs of 9 patients with NSCLC (5 resistant and 4 sensitive to EGFR TKI) with EGFR mutations. Interestingly, lung epithelial precursor-like cells with upregulated GNB2L1 and CAV1 expression were enriched in the EGFR TKI-resistant group. Moreover, GZMK upregulated transitional effector T cells, and plasmacytoid dendritic cells were significantly enriched in the EGFR TKI-resistant patients. Our results suggest that cellular plasticity and immunosuppressive microenvironment in MPEs are potentially associated with the TKI response of patients with EGFR-mutated NSCLC.